摘要:
Thyroxine containing pharmaceutical compositions with improved aqueous solubility, stability and enhanced membrane permeation have been prepared by formulating thyroxine with cyclodextrins. These thyroxine/cyclodextrin complexes can further be transformed into different dosage forms (oral tablets, injectables, transdermal patches, hydrogels, ointments, suppositories, etc.) by employing known, common pharmaceutical additives.
摘要:
The invention relates to a stable pharmaceutical effervescent formulation with metamizol and/or its pharmaceutically acceptable salts as active ingredients, wherein the pH of the corresponding solution is acidic.
摘要:
The invention concerns a process for the continuous agglomeration of granules intended for use in the production of compressed articles such as pharmaceutical preparations in tablet form.
摘要:
The invention relates to a patch for transdermal application with an outer covering layer, a self-adhesive matrix and a removable protective layer or with an outer covering layer, a reservoir, an adhesive component and a removable protective layer, wherein the matrix or the reservoir contains, as the active substance, tacrine or one of its pharmaceutically compatible salts.
摘要:
Non-deliquescent formulation comprising or consisting of sodium valproate and cyclodextrin having a molar ratio of sodium valproate to cyclodextrin within the range of from 1:0.01 to 1:0.09.
摘要:
The invention concerns a slow-release tablet containing diclofenac-Na as the active ingredient and methylhydroxypropylcellulose as the retarding agent.